Abstract
Background: The basic cause of angina pectoris is imbalance between the metabolic needs of the myocardium and the capacity of the coronary circulation to deliver sufficient oxygenated blood to satisfy these needs.
Hypothesis: The study was undertaken to evaluate whether the effect of combined amlodipine and atenolol therapy on patients with stable angina pectoris and with ST‐depression during exercise testing and 48‐h ambulatory electrocardiographic monitoring is superior to that of either agent given alone.
Methods: Patients with stable angina pectoris and ST depression during exercise and ambulatory monitoring were randomized to receive amlodipine (n = 116) or atenolol (n = 116), or both (n = 119). All patients were also treated with short‐ and long‐acting nitrates. The design was a double‐blind, randomized, triple‐arm parallel group study with 10 weeks of administration of the test medication.
Results: In terms of time to onset of ST depression > 1 mm, time to onset of angina, total exercise time, maximum achieved workload, and peak intensity of angina, amlodipine and atenolol alone were as effective as their combination. During ambulatory monitoring, atenolol was more effective than amlodipine regarding total time and number of ST‐depression episodes, and as effective as the combined drugs.
Conclusion: For individual patients with stable angina pectoris, combination of a beta blocker with a calcium antagonist is not necessarily more effective than either drug given alone.
Keywords: angina pectoris, amlodipine, atenolol, exercise test, ambulatory electrocardiographic monitoring
Full Text
The Full Text of this article is available as a PDF (712.9 KB).
References
- 1. Deanfield JE, Maseri A, Selwyn AP: Myocardial ischaemia during daily life in patients with stable angina: Its relation to symptoms and heart‐rate changes. Lancet 1983; 11: 753–758 [DOI] [PubMed] [Google Scholar]
- 2. Chierchia S, Lazzari M, Simonetti I, Maseri A: Haemodynamic monitoring in angina at rest. Herz 1980; 5: 189–198 [PubMed] [Google Scholar]
- 3. Tolins M, Weir EK, Chester E, Pierpont GL: “Maximal” drug therapy is not necessarily optimal in chronic angina pectoris. J Am Coll Cardiol 1984; 18: 1051–1057 [DOI] [PubMed] [Google Scholar]
- 4. Packer M: Combined beta‐adrenergic and calcium‐entry blockade in angina pectoris. N Engl J Med 1989; 320: 709–718 [DOI] [PubMed] [Google Scholar]
- 5. Savonitto S, Ardissiono D, Egstrup K, Rasmussen K, Bae EA, Omland T, Schjelderup‐Mathiesen PM, Marraccini P, Wahlqvist I, Martini PA, Rehnqvist N: Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study. J Am Coll Cardiol 1996; 27: 311–316 [DOI] [PubMed] [Google Scholar]
- 6. Guidelines on management of stable angina pectoris . Recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 1997; 18: 394–413 [DOI] [PubMed] [Google Scholar]
- 7. Borg G: Psychophysical bases of perceived exertion. Med Sci Sports Exercise 1982; 14: 377–382 [PubMed] [Google Scholar]
- 8. Crawford MH: The role of triple therapy in patients with chronic stable angina pectoris. Circulation 1987; 75 (suppl V): V‐122 [PubMed] [Google Scholar]
- 9. Furberg C, Patsy BM, Meyer JV: Nifedipine dose related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1326–1331 [DOI] [PubMed] [Google Scholar]
- 10. Strauss WE, Parisi AF: Combined use of calcium‐channel and beta‐adrenergic blockers for the treatment of chronic stable angina. Ann Intern Med 1988; 109: 570–581 [DOI] [PubMed] [Google Scholar]
- 11. Leon MB, Douglas DR, Bonow RO, Epstein SE: Combination therapy with calcium‐channel blockers and beta‐blockers for chronic stable angina pectoris. Am J Cardiol 1985; 55: 69B–80B12. [DOI] [PubMed] [Google Scholar]
- 12. Boden WE, Bough EW, Reichmann MJ, Rich VB, Young PM, Korr KS, Shulman RS: Beneficial effects of high‐dose diltiazem in patients with persistent effort angina on beta‐blockers and nitrates: A randomised, double‐blind, placebo‐controlled, cross‐over study. Circulation 1985; 71: 1197–1205 [DOI] [PubMed] [Google Scholar]
- 13. Nesto RW, White HD, Ganz P, Koslowski J, Wynne J, Holman BL, Antman E: Addition of nifedipine to maximal beta blocker‐nitrate therapy: Effects on exercise capacity and global ventricular performance at rest and during exercise. Am J Cardiol 1985; 55: 3E–8E [DOI] [PubMed] [Google Scholar]
- 14. Tweddel AC, Beattie JM, Murray RG, Hutton I: The combination of nifedipine and propranolol in the management of patients with angina pectoris. Br J Clin Pharmacol 1981; 12: 229–233 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Humen DP, O'Brian P, Purves P, Johnson D, Kostuk WJ: Effort angina with adequate beta‐receptor blockade: Comparison with diltiazem alone and in combination. J Am Coll Cardiol 1986; 7: 329–335 [DOI] [PubMed] [Google Scholar]
- 16. Winniford MD, Huxley RL, Hillis LD: Randomized, double‐blind comparison of propranolol alone and a propranolol‐verapamil combination in patients with severe angina of effort. J Am Coll Cardiol 1983; 1: 492–498 [DOI] [PubMed] [Google Scholar]
- 17. Woodmansey PA, Stewart AG, Morice AH, Channer KS: Amlodipine in patients with angina uncontrolled by atenolol. A double‐blind placebo controlled cross over trial. Eur J Clin Pharmacol 1993; 45: 107–111 [DOI] [PubMed] [Google Scholar]
- 18. Lynch P, Dargie HJ, Krikler S, Krikler D: Objective assessment of antianginal treatment: A double‐blind comparison of propranolol, nifedipine and their combination. Br Med J 1980; 11: 184–187 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Singh S, Doherty J, Udhoji V, Smith K, Gorwit J, Bekheit S, Mather S, Stein W, San Fellipo J, Hearan P, Chen Y, Taylor C: Amlodipine versus nadolol in patients with stable angina pectoris. Am Heart J 1989; 118: 1137–1138 [DOI] [PubMed] [Google Scholar]
- 20. Taylor SH: The efficacy of amlodipine in myocardial ischemia. Am Heart J 1989; 118: 1123–1126 [DOI] [PubMed] [Google Scholar]
- 21. Pehrsson SK, Tolagen K, Ulvenstam G: Efficacy and safety of amlodipine compared with diltiazem in patients with stable angina pectoris. Clin Drug Invest 1996; 11: 313–319 [Google Scholar]
- 22. Packer M, O'Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, Miller AB, Neuberg GW, Frid D, Wertheimer JH, Cropp AB, De Metz DL: Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996; 335: 1107–1114 [DOI] [PubMed] [Google Scholar]
- 23. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EN, Shusterman NH: Effect of carvedilol on morbidity and mortality in chronic heart failure. N Engl J Med 1996; 334: 1349–1355 [DOI] [PubMed] [Google Scholar]
- 24. Fox KM, Mulcahy D, Findlay I, Ford I, Dargie HJ: The Total Ischaemic Burden European Trial (TIBET): Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. Eur Heart J 1996; 17: 96–103 [DOI] [PubMed] [Google Scholar]
- 25. Deanfield JE, Detry J‐M, Lichtlen PR, Magnani B, Sellier P, Thaulow E: Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: Double‐blind Orcadian Antiischemia Program in Europe (CAPE Trial). J Am Coll Cardiol 1994; 24: 1460–1467 [DOI] [PubMed] [Google Scholar]
- 26. Davies RF, Habibi H, Klinke WP, Dessain P, Nadeau C, Phaneuf DC, Lepage S, Raman S, Herbert M, Foris K, Linden W, Buttars JA: Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. J Am Coll Cardiol 1995; 25: 619–625 [DOI] [PubMed] [Google Scholar]